Fig. 3From: ANLN and UBE2T are prognostic biomarkers associated with immune regulation in breast cancer: a bioinformatics analysisPan-cancer ANLN and UBE2T expression analysis. A ANLN expression in tumor and normal tissues from TCGA pan-cancer data. B UBE2T expression in tumor and normal tissues from TCGA pan-cancer data. C ANLN expression in normal tissues and breast cancer tissues from GSE50567. D, E ANLN expression in different subtypes of breast cancer tissues from GSE65194 and GSE43358. F UBE2T expression in normal tissues and breast cancer tissues from GSE50567. G, H UBE2T expression in different subtypes of breast cancer tissues from GSE65194 and GSE43358Back to article page